SZ3-17701-61177
4 vaccinations
1 coded response
28 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 871 / NM
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-07
- 2021-01-12
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
-
2021-11-05
Dose 3 — Moderna
- 2022-01-14
- 2022-02-08
- 2022-05-06
-
2022-09-15
Dose 4 — Pfizer-BioNTech
-
2022-11-05
Survey response — 12 months, dose 3MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-15
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 12 — 12 months, dose 3
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release